Kodiak Sciences

DescriptionKodiak Sciences Inc. is a fast-growing clinical-stage biopharmaceutical company focused on transforming ophthalmology through innovative therapeutics. Our Antibody Biopolymer Conjugate Drug (ABCD) platform combines protein engineering polymer chemistry small molecule drug d

DescriptionKodiak Sciences Inc. is a fast-growing clinical-stage biopharmaceutical company focused on transforming ophthalmology through innovative therapeutics. Our Antibody Biopolymer Conjugate Drug (ABCD) platform combines protein engineering polymer chemistry small molecule drug d

DescriptionKodiak Sciences Inc. is a rapidly growing clinical-stage biopharmaceutical company dedicated to transforming ophthalmology through innovative therapeutics. Our proprietary Antibody Biopolymer Conjugate Drug (ABCD) platform integrates protein engineering polymer chemistry sm

DescriptionKodiak Sciences Inc. is a rapidly growing clinical-stage biopharmaceutical company dedicated to transforming ophthalmology through innovative therapeutics. Our proprietary Antibody Biopolymer Conjugate Drug (ABCD) platform integrates protein engineering polymer chemistry sm

DescriptionKodiak Sciences is a biopharmaceutical company committed to researching developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases. We are focused on bringing new science to the design and manufacture of next-generation retinal

DescriptionKodiak Sciences is a biopharmaceutical company committed to researching developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases. We are focused on bringing new science to the design and manufacture of next-generation retinal

DescriptionKodiak Sciences is a fast-growing clinical-stage biotechnology company with a strong focus in ophthalmology. Our Antibody Biopolymer Conjugate Drug (ABCD) platform merges the fields of protein engineering organic chemistry and polymer chemistry and is at the core of our dis

DescriptionKodiak Sciences is a fast-growing clinical-stage biotechnology company with a strong focus in ophthalmology. Our Antibody Biopolymer Conjugate Drug (ABCD) platform merges the fields of protein engineering organic chemistry and polymer chemistry and is at the core of our dis